Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand.
van Turenhout ST, Terhaar sive Droste JS, Meijer GA, Masclée AA, Mulder CJ.
BMC Cancer. 2012 Jan 26;12:46.
Related citations
Identification of a biomarker panel for colorectal cancer diagnosis.
García-Bilbao A, Armañanzas R, Ispizua Z, Calvo B, Alonso-Varona A, Inza I, Larrañaga P, López-Vivanco G, Suárez-Merino B, Betanzos M.
BMC Cancer. 2012 Jan 26;12:43.
A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients.
Lang AH, Geller-Rhomberg S, Winder T, Stark N, Gasser K, Hartmann B, Kohler B, Grizelj I, Drexel H, Muendlein A.
BMC Cancer. 2012 Jan 17;12:20.
Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy.
Fahmueller YN, Nagel D, Hoffmann RT, Tatsch K, Jakobs T, Stieber P, Holdenrieder S.
BMC Cancer. 2012 Jan 4;12:5. doi: 10.1186/1471-2407-12-5.
Decreased expression of 17β-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon.
Rawłuszko AA, Horbacka K, Krokowicz P, Jagodziński PP.
BMC Cancer. 2011 Dec 19;11:522.
SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer.
Neumann J, Bahr F, Horst D, Kriegl L, Engel J, Luque RM, Gerhard M, Kirchner T, Jung A.
BMC Cancer. 2011 Dec 14;11:518.
Identification of α(1,6)fucosylated proteins differentially expressed in human colorectal cancer.
Muinelo-Romay L, Villar-Portela S, Cuevas E, Gil-Martín E, Fernández-Briera A.
BMC Cancer. 2011 Dec 7;11:508.
Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer.
Dahan L, Norguet E, Etienne-Grimaldi MC, Formento JL, Gasmi M, Nanni I, Gaudart J, Garcia S, Ouafik L, Seitz JF, Milano G.
BMC Cancer. 2011 Nov 25;11:496.
Fast track multi-discipline treatment (FTMDT trial) versus conventional treatment in colorectal cancer--the design of a prospective randomized controlled study.
Zhou JJ, Li J, Ying XJ, Song YM, Chen R, Chen G, Yan M, Ding KF.
BMC Cancer. 2011 Nov 24;11:494.
Error occurred: cannot get document summary
Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa.
Enroth S, Rada-Iglesisas A, Andersson R, Wallerman O, Wanders A, Påhlman L, Komorowski J, Wadelius C.
BMC Cancer. 2011 Oct 19;11:450.
Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival.
Birgisson H, Wallin U, Holmberg L, Glimelius B.
BMC Cancer. 2011 Oct 11;11:438.
The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer.
Grossmann I, Klaase JM, Avenarius JK, de Hingh IH, Mastboom WJ, Wiggers T.
BMC Cancer. 2011 Oct 7;11:433.
Activating mutation in MET oncogene in familial colorectal cancer.
Neklason DW, Done MW, Sargent NR, Schwartz AG, Anton-Culver H, Griffin CA, Ahnen DJ, Schildkraut JM, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Burt RW.
BMC Cancer. 2011 Oct 4;11:424.
A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer.
Reissfelder C, Timke C, Schmitz-Winnenthal H, Rahbari NN, Koch M, Klug F, Roeder F, Edler L, Debus J, Büchler MW, Beckhove P, Huber PE, Weitz J.
BMC Cancer. 2011 Sep 30;11:419.
The extramural metastasis might be categorized in lymph node staging for colorectal cancer.
Qiu HB, Chen G, Keshari RP, Luo HY, Fang W, Qiu MZ, Zhou ZW, Xu RH.
BMC Cancer. 2011 Sep 26;11(1):414.
Knowledge and attitudes of primary healthcare patients regarding population-based screening for colorectal cancer.
Ramos M, Llagostera M, Esteva M, Cabeza E, Cantero X, Segarra M, Martín-Rabadán M, Artigues G, Torrent M, Taltavull JM, Vanrell JM, Marzo M, Llobera J.
BMC Cancer. 2011 Sep 25;11(1):408.
An ecological analysis of colorectal cancer incidence and mortality: differences by sexual orientation.
Boehmer U, Ozonoff A, Miao X.
BMC Cancer. 2011 Sep 21;11:400.
The association between socio-demographic characteristics and adherence to breast and colorectal cancer screening: analysis of large sub populations.
Wilf-Miron R, Peled R, Yaari E, Vainer A, Porath A, Kokia E.
BMC Cancer. 2011 Aug 25;11:376.
Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S.
BMC Cancer. 2011 Aug 24;11:371.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on